These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 1181022)

  • 1. Porphyria cutanea tarda: comparison of cases precipitated by alcohol and estrogens.
    Haberman HF; Rosenberg F; Menon IA
    Can Med Assoc J; 1975 Oct; 113(7):653-5. PubMed ID: 1181022
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Porphyria cutanea tarda: clinical and laboratory features.
    Sweeney GD; Jones KG
    Can Med Assoc J; 1979 Apr; 120(7):803-7. PubMed ID: 427687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative trial of desferrioxamine and hydroxychloroquine for treatment of porphyria cutanea tarda in alcoholic patients.
    Marchesi L; Di Padova C; Cainelli T; Reseghetti A; Di Padova F; Rovagnati P; Cantoni L
    Photodermatol; 1984 Dec; 1(6):286-92. PubMed ID: 6398430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transdermal estrogen replacement therapy in postmenopausal women previously treated for porphyria cutanea tarda.
    Bulaj ZJ; Franklin MR; Phillips JD; Miller KL; Bergonia HA; Ajioka RS; Griffen LM; Guinee DJ; Edwards CQ; Kushner JP
    J Lab Clin Med; 2000 Dec; 136(6):482-8. PubMed ID: 11128750
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phlebotomy treatment of porphyria cutanea tarda.
    Lundvall O
    Acta Derm Venereol Suppl (Stockh); 1982; 100():107-18. PubMed ID: 6962627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of hepatitis C virus (HCV) infection on porphyrin and iron metabolism in porphyria cutanea tarda (PCT) patients.
    Dabrowska E; Jabłońska-Kaszewska I; Bielawski KP; Falkiewicz B
    Med Sci Monit; 2001 May; 7 Suppl 1():190-6. PubMed ID: 12211718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Iron metabolism and chloroquine phosphate therapy in porphyria cutanea tarda].
    Köstler E; Pollack P; Seebacher C; Riedel H
    Z Hautkr; 1990 Nov; 65(11):1030-2, 1035. PubMed ID: 2080653
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Determination of serum ferritin in porphyria cutanea tarda. A reliable sign of hepatic siderosis].
    Gibertini P; Rocchi E; Cassanelli M; Pietrangelo A; Coppini M; Ventura E
    Minerva Med; 1984 Mar; 75(9-10):469-74. PubMed ID: 6709223
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral contraceptives and porphyria cutanea tarda.
    Behm AR; Unger WP
    Can Med Assoc J; 1974 May; 110(9):1052-4. PubMed ID: 4823112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Results of treatment of porphyria cutanea tarda with bloodletting and chloroquine].
    Seubert S; Seubert A; Stella AM; Guzman H; Batlle A
    Z Hautkr; 1990 Mar; 65(3):223-5. PubMed ID: 2339575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haem biosynthesis and human porphyria cutanea tarda: effects of alcohol intake.
    Mukerji SK
    Indian J Exp Biol; 2000 Jul; 38(7):635-42. PubMed ID: 11215304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The difference in liver pathology between sporadic and familial forms of porphyria cutanea tarda: the role of iron.
    Siersema PD; Rademakers LH; Cleton MI; ten Kate FJ; de Bruijn WC; Marx JJ; Wilson JH
    J Hepatol; 1995 Sep; 23(3):259-67. PubMed ID: 8550989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of vitamin E administration on the hemorheological status and redox homeostasis of patients with porphyria cutanea tarda treated with phlebotomy.
    Székely E; Vereckei A; Almási A; Rapavi E; Tasnádi G; Várnai K; Pallai Z; Lugasi A; Blázovics A
    Clin Hemorheol Microcirc; 2007; 36(1):13-23. PubMed ID: 17211058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of nicotinic acid administration on serum levels of bilirubin and iron in patients with porphyria cutanea tarda.
    Gentile S; Ayala F; Orlando C; Santoianni P; Budillon G
    Scand J Clin Lab Invest; 1988 Nov; 48(7):641-5. PubMed ID: 3201096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of porphyrin-excretion in female estrogen-induced porphyria cutanea tarda.
    Enríquez de Salamanca R; Mingo D; Chinarro S; Muñoz JJ; Perpiñá J
    Arch Dermatol Res; 1982; 274(1-2):179-84. PubMed ID: 7165364
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Results of clinical and chemical studies in porphyria cutanea tarda].
    Formanek I; Niebauer G
    Wien Z Inn Med; 1966 Nov; 47(11):438-44. PubMed ID: 6005177
    [No Abstract]   [Full Text] [Related]  

  • 17. [Quantitative liver function tests in porphyria cutanea tarda: improvement under therapeutic phlebotomy].
    Meister F; Reichen J
    Schweiz Med Wochenschr; 1986 Mar; 116(11):341-5. PubMed ID: 3961453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose tolerance in adult Ethiopian patients with liver disease and porphyria cutanea tarda.
    Mengistu M; Gebreselassie F; Tsega E
    Ethiop Med J; 1989 Jul; 27(3):107-14. PubMed ID: 2753029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Porphyria cutanea tarda revealed by voriconazole].
    Hickman G; Duval A; Picard C; Petit A
    Ann Dermatol Venereol; 2010 Jan; 137(1):36-9. PubMed ID: 20110066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Significance and prevalence of the C282Y gene mutation of primary hemochromatosis in the pathogenesis of pophyria cutanea tarda].
    Malina L; Zd'árský E; Dandová S; Michalíková H; Cerná M; Cimburová M
    Cas Lek Cesk; 2000 Nov; 139(23):728-30. PubMed ID: 11191743
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.